Injective price outlook: Downward momentum limits rebound potential

Injective price outlook: Downward momentum limits rebound potential
Injective drops 7.79% today to $6.64

Injective (INJ) is trading at $6.64, down 7.79% on the day. The price sits below its key short- and medium-term moving averages, while remaining above its longer-term trend indicator.

INJ price prediction
24H -2.25%
$6.53
48H -2.54%
$6.51
7D -19.16%
$5.4
1M -12.87%
$5.82
3M -67.07%
$2.2
6M -79.04%
$1.4
12M 16.17%
$7.76
Current price: $6.68 -0.45 6.30%
Real-time Data 10:12
Daily range 6.6 Arrow from to Icon 6.99
Weekly range 6.56 Arrow from to Icon 8.44
Loading...

Highlights

  • Injective will introduce the Veyra Mainnet Upgrade to enable institutional adoption and support tokenized financial products.
  • The network development targets expanded use cases for institutional and traditional finance engagement with real-world asset markets.
  • INJ trades below key moving averages with most momentum indicators negative, projecting a high probability of further declines toward the $6.22 to $7.06 range.

Institutional support expands as mainnet upgrade counters selling pressure

The Injective team has announced the upcoming Veyra Mainnet Upgrade, introducing features intended to support institutional adoption, real-world asset markets, and new classes of tokenized financial products, according to Cryptowisser. This protocol development aims to broaden the platform's functionality and offers potential for expanded use cases among institutional and traditional finance participants. These enhancements represent ongoing investment in network capabilities, though price action has remained under broader selling pressure.

Injective asset chart
Injective price dynamics. Source: TradingView.

Momentum remains bearish as resistance intensifies near key moving averages

INJ is currently positioned below the MA-20 and MA-50, reflecting near-term and medium-term resistance from sellers, but continues to trade above the MA-200, which now acts as longer-term support. The Ichimoku Kijun at $6.95 sits as immediate resistance for any attempted price recovery. Momentum indicators show MACD and ADX in Sell mode, while the Awesome Oscillator also signals further downside; Bull/Bear Power remains negative, underscoring strong intraday selling momentum. RSI registers as neutral, but both Stoch RSI and CCI are deeply oversold, indicating that downside momentum could be losing steam and a short-term rebound risk is present.

Downside risk persists as volatility tempers potential rebound

Short-term expectations for INJ call for continued high volatility, with price likely consolidating between $6.22 and $7.06 in the next two to three trading days. The probability of a break lower remains significantly elevated versus the likelihood of a sustained reversal. A move above $6.95 would be required to shift sentiment toward a potential bullish scenario, while a decline through $6.22 could trigger further selling within the typical volatility band for this asset.

Anton Kharitonov, expert at Traders Union, sees persistent selling pressure on INJ despite ongoing improvements at the protocol level. He notes that the Veyra Mainnet Upgrade could support longer-term adoption, but near-term technicals and momentum indicators point toward further risk. The analyst remains cautious until resistance at $6.95 is reclaimed. "Unless INJ can break back above key resistance, I consider the bounce attempts fragile and favor a defensive stance."

Earlier, analysts noted that Injective was contending with persistent volatility and a modest downside bias, despite ongoing protocol upgrades and strong community support. The current analysis deepens this view, as technical pressures remain heightened and volatility is expected to persist, with the $6.22 level now emerging as a critical threshold for further downside risk.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.